Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alpha TeknovaTKNO +0.56%63 FCF Margin % is -32.32% as of Mar. 2026. GuruFocus rates TKNO with a GF Score™ of 63/100 and a GF Value™ of $3.55 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 961 Drug Manufacturers companies, Alpha Teknova ranks worse than 82.62% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Alpha Teknova's Free Cash Flow for the
three
months ended in Mar. 2026 was $-3.58 Mil. Alpha Teknova's Revenue for the
three
months ended in Mar. 2026 was $11.08 Mil. Therefore, Alpha Teknova's FCF Margin % for the quarter that ended in Mar. 2026 was -32.32%.
The historical rank and industry rank for Alpha Teknova's FCF Margin % or its related term are showing as below:
TKNO'
s FCF Margin % Range Over the Past 10 Years
Min: -134.11 Med: -35.81 Max: -2.37
Current: -21.69
During the past 7 years, the highest FCF Margin % of Alpha Teknova was -2.37%. The lowest was -134.11%. And the median was -35.81%.
TKNO's FCF Margin % is ranked worse than 82.62% of 961
companies
in the Drug Manufacturers industry
Industry Median: 2.59
vs TKNO: -21.69
Alpha Teknova FCF Margin % Related Terms
Alpha Teknova FCF Margin % Historical Data
* Premium members only.
The historical data trend for Alpha Teknova's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Alpha Teknova's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpha Teknova FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Alpha Teknova's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Alpha Teknova's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alpha Teknova (TKNO) has a FCF Margin % of -32.32% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Alpha Teknova and its competitors. According to the industry distribution chart, Alpha Teknova ranks #794 out of 961 companies in the Drug Manufacturers industry, placing it in the top 82.6%.
Is Alpha Teknova's FCF Margin % too high?
Alpha Teknova's current FCF Margin % is -32.32%. Based on the distribution chart, Alpha Teknova ranks #794 out of 961 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Alpha Teknova has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alpha Teknova's FCF Margin % compare to AKBA and ORGO?
According to the Drug Manufacturers industry distribution chart, Alpha Teknova ranks #794 out of 961 companies for FCF Margin %. This places Alpha Teknova in the lower half of its industry. The industry median FCF Margin % is 2.59. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.59, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Alpha Teknova and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpha Teknova's current FCF Margin % is -32.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Teknova stock overvalued right now?
Based on GuruFocus' analysis, Alpha Teknova (TKNO) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.55, compared to a current price of $5.34 — trading 50.4% above its estimated fair value. The current FCF Margin % is -32.32%. Alpha Teknova's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Alpha Teknova (TKNO), the current FCF Margin % is -32.32% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alpha Teknova (TKNO) Overvalued in 2026?
Based on GuruFocus' analysis, Alpha Teknova stock appears to be overvalued.
The current stock price of $5.34 is trading 50.4% above its estimated GF Value™ of $3.55.
GuruFocus considers Alpha Teknova to be Significantly Overvalued.
Key valuation signals for TKNO:
FCF Margin %: -32.32%
GF Value™: $3.55 vs. price of $5.34 (50.4% above fair value)
No single metric tells the full story. See the TKNO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
63GF Score
Get the complete analysis for TKNO
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TKNO has been successfully added to your 
